PRMT8 and ovarian carcinoma: PRMT8 had been reported to be involved in the prognosis of a variety of tumors, with high expression of PRMT8 associated with a good prognosis in breast and ovarian cancers and poor prognosis in gastric cancer (Hernandez et al., 2017).